Dublin, Nov. 08, 2023 (GLOBE NEWSWIRE) -- The "Xerostomia (Dry Mouth Disease) Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028" report has been added to ResearchAndMarkets.com's offering.
The global xerostomia (dry mouth disease) therapeutics market size reached US$ 714 Million in 2022. Looking forward, the market is set to reach US$ 893 Million by 2028, exhibiting a growth rate (CAGR) of 3.6% during 2023-2028.
The increasing incidences of dry mouth, especially amongst the geriatric population, due to medicine side-effects of radiotherapy and chemotherapy and the rising need for dry mouth relief products are primarily driving the market growth.
Additionally, the growing uptake of several prescription-based toothpaste, vitamin gummies, and medicines for treating Sjogren's syndrome, Alzheimer's diseases, and human immunodeficiency virus (HIV) that cause xerostomia is acting as another growth-inducing factor.
In line with this, the rising consumer awareness regarding the early diagnosis of xerostomia, significant enhancements in healthcare expenditure, and the advent of diverse diagnostic technologies are propelling the market growth. Moreover, the favorable initiatives being commenced by governments to sensitize consumers regarding the xerostomia disease, its symptoms, causes, and treatments are impelling the market growth.
Apart from this, the easy availability of various therapeutic drugs and ongoing research and development (R&D) activities are creating a positive outlook for the market.
Key Questions Answered in This Report
- How big is the global xerostomia (dry mouth disease) therapeutics market?
- What is the expected growth rate of the global xerostomia (dry mouth disease) therapeutics market during 2023-2028?
- What are the key factors driving the global xerostomia (dry mouth disease) therapeutics market?
- What has been the impact of COVID-19 on the global xerostomia (dry mouth disease) therapeutics market?
- What is the breakup of the global xerostomia (dry mouth disease) therapeutics market based on type?
- What is the breakup of the global xerostomia (dry mouth disease) therapeutics market based on the drug type?
- What is the breakup of the global xerostomia (dry mouth disease) therapeutics market based on the distribution channel?
- What are the key regions in the global xerostomia (dry mouth disease) therapeutics market?
- Who are the key players/companies in the global xerostomia (dry mouth disease) therapeutics market?
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 147 |
| Forecast Period | 2022 - 2028 |
| Estimated Market Value (USD) in 2022 | $714 Million |
| Forecasted Market Value (USD) by 2028 | $893 Million |
| Compound Annual Growth Rate | 3.8% |
| Regions Covered | Global |
Competitive Landscape
The competitive landscape of the industry has also been examined along with the profiles of the key players being
- 3M Company
- Biotene (GSK plc)
- Parnell Pharmaceuticals Inc.
- Quest Products LLC
- Saliwell Ltd
- Sun Pharmaceutical Industries Limited
- West-Ward Pharmaceutical (Hikma Pharmaceuticals plc)
Key Market Segmentation
Breakup by Type:
- Artificial Saliva/Saliva Substitutes
- Salivary Stimulants
Breakup by Drug Type:
- OTC
- Prescription
Breakup by Distribution Channel:
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
For more information about this report visit https://www.researchandmarkets.com/r/qisfco
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
